David Cogdell

4.0k citations

47 papers · 2.6k indexed · h-index 27

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation

Papers in

Cancer Research 16
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 7
Molecular Biology 37
- Gene expression and cancer classification 7
- Circular RNAs in diseases 7
- Molecular Biology Techniques and Applications 4
- Advanced Biosensing Techniques and Applications 4

Co-authors: Limei Hu Kexin Chen Matti NykterWei ZhangStanley R. Hamilton Ilya Shmulevich Hanyin Cheng Da Yang
Journals: Technology in Cancer Research & Treatment (3 papers)The Journal of Pathology (3 papers)Proceedings of the National Academy of Sciences (3 papers)Cancer Biology & Therapy (2 papers)Modern Pathology (2 papers)
Partner nations: United States China Russia

In The Last Decade

David Cogdell

47 papers receiving 2.6k citations

Peers

Countries citing papers authored by David Cogdell

Since Specialization

Citations

This map shows the geographic impact of David Cogdell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cogdell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cogdell more than expected).

Fields of papers citing papers by David Cogdell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cogdell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cogdell. The network helps show where David Cogdell may publish in the future.

Co-authors

The 25 scholars most cited alongside David Cogdell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Cogdell Line = papers co-authored together David Cogdell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test European Urology Focus ·Shizhen Zhang, Yan Wang, Jolanta Bondaruk, Tadeusz Majewski, Hui Yao, Sangkyou Lee, Concert Spirituel, David Cogdell, Yair Lotan, Colin P. Dinney, Peng Wei, Keith Baggerly, Bogdan Czerniak	2018	4
2	Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use EBioMedicine ·Vipulkumar Dadhania, Miao Zhang, Li Zhang, Jolanta Bondaruk, Tadeusz Majewski, Arlene O. Siefker‐Radtke, Charles C. Guo, Colin P. Dinney, David Cogdell, Shizhen Zhang, Sangkyou Lee, Cecilia Mueller, John N. Weinstein, Keith Baggerly, David J. McConkey, Bogdan Czerniak	2016	248
3	MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis Journal of Hematology & Oncology ·Yingmei Wang, Limei Hu, Ping Ji, Fei Teng, Wenyan Tian, Yuexin Liu, David Cogdell, Jinsong Liu, Anil K. Sood, Russell R. Broaddus, T.L. Mellichamp, Wei Zhang	2016	19
4	IGFBP2 potentiates nuclear EGFR–STAT3 signaling Oncogene ·Corrine Ying Xuan Chua, Yi Liu, S. Kiortsis, Limei Hu, Hannu Haapasalo, Matti Annala, David Cogdell, Elizabeth H. Thompson, G.A. Sazhina, Gregory N. Fuller, Matti Nykter, Webster K. Cavenee, Wei Zhang	2015	66
5	miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma Oncology Reports ·Fei Guo, David Cogdell, Limei Hu, Da Yang, Anil K. Sood, Fengxia Xue, Wei Zhang	2014	64
6	Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer Cancer Cell ·Da Yang, Yan Sun, Limei Hu, Hong Zheng, Ping Ji, Chad V. Pecot, Yanrui Zhao, Sheila M. Reynolds, Hanyin Cheng, Rajesha Rupaimoole, David Cogdell, Matti Nykter, Russell R. Broaddus, Cristian Rodriguez‐Aguayo, Gabriel Lopez‐Berestein, Jinsong Liu, Ilya Shmulevich, Anil K. Sood, Kexin Chen, Wei Zhang	2013	314
7	Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer Cancer Cell ·Da Yang, Yan Sun, Limei Hu, Hong Zheng, Ping Ji, Chad V. Pecot, Yanrui Zhao, Sheila M. Reynolds, Hanyin Cheng, Rajesha Rupaimoole, David Cogdell, Matti Nykter, Russell R. Broaddus, Cristian Rodriguez‐Aguayo, Gabriel Lopez‐Berestein, Jinsong Liu, Ilya Shmulevich, Anil K. Sood, Kexin Chen, Wei Zhang	2013	6
8	Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System Anesthesia & Analgesia ·Mohamed Naguib, Jijun Xu, Philippe Diaz, D Subbarao, David Cogdell, Bihua Bie, Jianhua Hu, Suzanne Craig, Walter N. Hittelman	2012	65
9	Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin As a Therapeutic Target in Castration-Resistant Prostate Cancer PLoS ONE ·Kanishka Sircar, Heng Huang, Limei Hu, Yuexin Liu, Jasreman Dhillon, David Cogdell, Armen Aprikian, Eleni Efstathiou, Nora M. Navone, Patricia Troncoso, Victor Wei Zhang	2012	14
10	Integrative Molecular Profiling Reveals Asparagine Synthetase Is a Target in Castration-Resistant Prostate Cancer American Journal Of Pathology ·Kanishka Sircar, Heng Huang, Limei Hu, David Cogdell, Jasreman Dhillon, Vassiliki Tzelepi, Eleni Efstathiou, Ismaël Hervé Koumakpayi, Fred Saad, Dijun Luo, Tarek A. Bismar, Ana M. Aparicio, Patricia Troncoso, Nora M. Navone, Wei Zhang	2012	68
11	Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis PLoS ONE ·Hanyin Cheng, Lína Zhang, David Cogdell, Hong Zheng, Aaron J. Schetter, Matti Nykter, Curtis C. Harris, Kexin Chen, Stanley R. Hamilton, Wei Zhang	2011	363
12	Integrated Proteomics and Genomics Analysis Reveals a Novel Mesenchymal to Epithelial Reverting Transition in Leiomyosarcoma through Regulation of Slug Molecular & Cellular Proteomics ·Jilong Yang, James A. Eddy, Yuan Pan, D. Prigent, Ioan Tăbuş, Yingmei Wang, David Cogdell, Nathan D. Price, Raphael E. Pollock, Alexander J. Lazar, Kelly K. Hunt, Jonathan C. Trent, Wei Zhang	2010	49
13	Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma Cancer Letters ·Jilong Yang, David Cogdell, Da Yang, Limei Hu, Haixin Li, M. V. Shcherbatyi, Xiaoling Du, Yi Pang, Jonathan C. Trent, Kexin Chen, Wei Zhang	2009	46
14	Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results Modern Pathology ·Ming Guo, Ching‐Yu Lin, Yun Yun Gong, David Cogdell, Wei Zhang, E. Lin, Nour Sneige	2008	14
15	Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway Cancer Biology & Therapy ·Woonyoung Choi, David Cogdell, Yingmei Feng, Stanley R. Hamilton, Wei Zhang	2006	20
16	Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays PROTEOMICS ·Rongcai Jiang, Orlagh Ryan, Ilya Shmulevich, David Cogdell, Yu Jia, Ioan Tăbuş, Kenneth Aldape, Raymond Sawaya, Janet M. Bruner, Gregory N. Fuller, Wei Zhang	2006	55
17	Recombinant human granulocyte–colony‐stimulating factor–mobilized and apheresis‐collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis Transfusion ·Martin Körbling, James M. Reuben, Hui Gao, Bang‐Ning Lee, David Harris, David Cogdell, Sergio Giralt, Issa F. Khouri, Rima M. Saliba, Richard E. Champlin, Wei Zhang, Zeev Estrov	2006	54
18	The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration Cancer Biology & Therapy ·J. Matthew McDonald, Sarah M. Dunlap, David Cogdell, Valerie Dunmire, Qingyi Wei, Anna Starzinski‐Powitz, Raymond Sawaya, Robert Edmund Bertram, Gregory N. Fuller, Kenneth Aldape, Wei Zhang	2006	32
19	Robust estimation of protein expression ratios with lysate microarray technology Computer applications in the biosciences ·Orlagh Ryan, Ilya Shmulevich, David Cogdell, Woonyoung Choi, Yu Jia, (unknown), Stanley R. Hamilton, Wei Zhang	2005	37
20	Monitoring of cDNA microarray with common primer target and hybridization specificity with selected targets. PubMed ·Limei Hu, David Cogdell, あい片岡, Stanley R. Hamilton, Wei Zhang	2002	5

About David Cogdell

David Cogdell is a scholar working on Cancer Research, Molecular Biology, Gastroenterology, Spectroscopy and Oncology, having authored 47 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (7 papers), Gene expression and cancer classification (7 papers), Circular RNAs in diseases (7 papers), Advanced Proteomics Techniques and Applications (4 papers), Molecular Biology Techniques and Applications (4 papers), Advanced Biosensing Techniques and Applications (4 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.8k citations), Oncology (477 citations), Genetics (134 citations) and Pulmonary and Respiratory Medicine (328 citations). David Cogdell has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Limei Hu, Kexin Chen, Matti Nykter, Wei Zhang, Stanley R. Hamilton, Ilya Shmulevich, Hanyin Cheng, Da Yang, Anil K. Sood and Yan Sun. Their work appears in journals such as Technology in Cancer Research & Treatment, The Journal of Pathology, Proceedings of the National Academy of Sciences, Cancer Biology & Therapy and Modern Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact